|
|
||||||||
1 Department of Respiratory Medicine, Birmingham Heartlands Hospital, Birmingham B9 5SS; and 2 St. Hugh's College, University of Oxford, Oxford OX2 6LE, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
Nasal
nitric oxide (NO) exchange dynamics are poorly understood but
potentially are of importance, inasmuch as they may provide insight
into the NO-related physiology of the bronchial tree. In healthy human
volunteers, NO output was assessed by isolating the nasal cavity
through elevation of the soft palate and application of tight-fitting
nasal olives. Mean NO output was 334 nl/min and was a positive
function of gas flow. With the use of a mathematical model and the
introduction of nonzero concentrations of NO, the diffusing capacity
for NO in the nose (DNO) and the mucosal NO concentration
(Cw) were determined. DNO ranged from 0.52 to
2.98 × 10
3
nl · s
1 · ppb
1 and
Cw from 1,236 to 8,947 ppb. Cw declined with
increasing gas flow, while DNO was constant. NO output
declined with luminal hypoxia, particularly at oxygen tensions <10%.
Measurement of nasal DNO and Cw is easy using
this method, and the range of intersubject values of Cw
raises the possibility of interindividual differences in NO-dependent
nasal physiology.
nasal; gas flow; oxygen tension; modeling
| |
INTRODUCTION |
|---|
|
|
|---|
NITRIC OXIDE (NO) is produced by the enzyme NO synthase (NOS) in many cells of the respiratory tract and plays an important role in host defense, regulation of ciliary activity and pulmonary blood flow, and possibly the matching of perfusion with ventilation in the lung (15). NO is a unique respiratory tract product, since it is gaseous and is produced by the epithelial cells lining the conducting airways and the nose (1, 8, 24, 30, 31, 34). The function of NO in the nose is not known, but it may play a role in host defense, and the nose may act as a source of pulmonary NO during nasal inspiration (25).
NO produced by NOS in airway walls may be excreted into the lumen in the gas phase, or it may diffuse submucosally, where it will combine avidly with heme (17) and other reactants (9). The exchange dynamics of NO are therefore very different from those of well-studied biological gases, such as CO2, which is excreted from the alveolar region of the lung. An understanding of these dynamics is fundamental to the development of our knowledge of the functions of NO in the respiratory tract.
Several features of these dynamics have been described. It is known that during breath holding, with no luminal gas flow, NO accumulates in the nose and in the bronchi (21), indicating that the rate of NO production exceeds the rate of submucosal diffusion at both sites, although accumulation of NO is more rapid in the nose (3, 21). When gas flows in the nose and bronchi, NO excretion on the luminal side increases (5, 11, 36). This feature of NO exchange dynamics has been suggested to occur as luminal gas flow leads to a lower luminal NO concentration ([NO]), in turn altering the equilibrium between luminal NO excretion and submucosal diffusion (36). There is no experimental evidence to support or refute this hypothesis. An alternative, and perhaps more intriguing, hypothesis would be that luminal gas flow directly affects NOS activity in epithelial cells, in an analogous fashion to luminal blood flow increasing NOS activity in vascular endothelial cells (28).
Pulmonary NO production is also known to be dependent on inspired oxygen tension (6, 32), presumably because oxygen is an NOS substrate (6, 22), and a recent study has suggested a similar relationship in the nose (13). Although some of the features of respiratory tract NO exchange dynamics have been studied in the lung, this approach is hampered by the complexity of pulmonary anatomy and physiology (40). Because the nasal cavity is of relatively fixed volume and is easily isolated and accessed, we sought to further define the exchange dynamics of NO in healthy human subjects in this organ as a first step in more accurately describing NO exchange in the bronchial tree. The specific aims of this study were to 1) determine whether nasal NO output is a positive function of luminal gas flow rate, 2) develop a mathematical model for use in the nose to determine the diffusing capacity for NO (DNO) and the mucosal [NO] [wall concentration (Cw)], 3) apply that model to determine DNO and Cw in healthy human subjects, 4) determine DNO and Cw at different luminal gas flow rates to define the mechanism of aim 1 (above) and 5) determine the relationship between luminal oxygen tension and nasal NO output.
| |
METHODS |
|---|
|
|
|---|
Apparatus.
A schematic for the apparatus used in the experiments is presented in
Fig. 1. Gas was available from two
cylinders, each fitted with a two-stage regulator; the gases were
blended using digital mass flow-controlled valves (model 5850S, Brooks
Instruments). Operating pressure was 1 bar. These valves allow the
delivery of flows of 0-1,000 and 0-2,000 ml/min,
respectively, with tolerance of <1% of maximum flow. For
experiment 1, a different valve, which delivered a flow rate
of 0.5-5 l/min (Rotork Analysis), was used. After it was blended,
the gas mix was delivered via polytetrafluoroethylene tubing to the
right nostril via a tight-fitting nasal olive. The [NO] in this gas
is referred to as [NO]in. Another tight-fitting nasal
olive was applied to the left nostril and connected via a T piece to
the sampling port of the chemiluminescence analyzer, where
[NO]out was determined.
|
Chemiluminescent analyzer. Concentrations of NO were detected using chemiluminescence (Logan 2000, Rochester, Kent, UK) in accordance with European Respiratory Society and American Thoracic Society guidelines (19, 35). The analyzer has a sensitivity of 0.3 ppb and is able to analyze at 25 Hz for up to 80 s continuously and in real time. Concurrent analysis of CO2 concentration is available, and the analyzer has a response time of <2 s. The sampling flow rate used during these experiments was ~4 ml/s. The analyzer was calibrated daily using a known standard (99 ppb NO in nitrogen) and zeroed before each experimental run.
Isolation of nasal cavity. The nasal cavity was effectively isolated through voluntary elevation of the soft palate during breath holding. The application of tight-fitting olives to the nares completed the isolation procedure. Soft palate closure was confirmed through the exclusion of CO2, and the adequacy of fit of the olives was confirmed by the rapid attainment of a stable plateau for NO (19, 35). Deliberate relaxation of the soft palate led to immediate release of CO2 into the sample, and deliberate dislodgement of the nasal olives led to immediate deterioration in the stability of [NO]out. These parameters were therefore carefully monitored to ensure effective isolation of the nasal cavity. Some subjects were unable to satisfactorily complete this maneuver and were excluded from further study. Subjects were asked to maintain breath holding and soft palate closure for 35 s. Equilibration occurred during the first 10-15 s of breath hold. [NO] for each experimental run was calculated from the mean of four measurements taken at 15, 20, 25, and 30 s after the commencement of breath hold.
Experiment 1: effect of luminal gas flow rate on nasal NO output. Six healthy, nonsmoking subjects (25-35 yr old, 3 men and 3 women), all of whom were able to complete the nasal isolation maneuver, were recruited. Inasmuch as nasal NO output increases within 3 wk of common cold infection (27), subjects who had had an upper respiratory tract infection in the previous 6 wk were excluded from further study, as were those taking any form of medication. Only one of the cylinders was used for this experiment, and gas blending was not necessary (Fig. 1). Medical air (21% oxygen-79% nitrogen, <1 ppb NO) was infused into the right nostril at 10 different gas flow rates in random order (0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, and 5 l/min), and the gas escaping from the left nostril was analyzed for NO ([NO]out). Each experimental run was completed six times for each subject at each of the 10 flow rates. Nasal NO output (nl/min) was calculated from NOout (ppb) × gas flow rate (l/min), according the recommendations of the American Thoracic Society (35).
Experiment 2: effect of luminal NO concentration on [NO]out. Eight healthy, nonsmoking subjects (20-31 yr old, 5 men and 3 women) were recruited. Again, none had had an upper respiratory tract infection for the previous 6 wk or were taking any medication, and all were able to satisfactorily complete the nasal cavity isolation maneuver. NO (49 ppm) in nitrogen and medical air (21% oxygen) were used. The gases were blended to produce air with nominal [NO] of 0, 500, 1,000, and 2,000 ppb at each of two total flow rates (1 and 2 l/min). Because the flow rate for the NO in nitrogen gas was very low compared with the flow rate of the medical air, the final oxygen concentration varied little from 21%. At the lowest [NO], the mass flow-controlled valve was operating near the limit of its tolerance, so before each experimental run, the actual [NO] delivered ([NO]in) was measured over 30 s by direct sampling from the right nasal olive and verified to be stable before introduction of the gas mix into the right nostril. The eight different flow-[NO]in combinations were applied to the right nostril of each subject, each for three experimental runs, in random order. For each subject, NOout was plotted against NOin.
Silkoff et al. (37) developed a theoretical model for NO exchange dynamics in the lower respiratory tract. In their model, gas flows along a cylindrical tube with an initial [NO] [alveolar concentration (Calv)] that increases monotonically as NO is added along the tube in proportion to the concentration gradient between the airway wall (Cw) and the lumen. Eventually, an exit concentration (Ce) is reached. The mathematical description of this process is
|
(1) |
is the luminal gas flow rate
(37). A more complicated model, developed by Tsoukias and
George (40), takes into account the branching nature of
the bronchial tree. For the more simple case in the nose, the two
models are equivalent (a proof is available on request). The model of
Silkoff et al. can be conveniently generalized to the nose, with
Cw = [NO] at the interface between nasal mucosa and
lumen (in ppb), Ce = [NO]out (ppb),
Calv = [NO]in (ppb),
DNO = diffusing capacity for NO in the nose
(nl · s
1 · ppb
1), and
= gas flow through the lumen of the nasal cavity (l/s); thus
|
(2) |
|
(3) |
Experiment 3: effect of luminal oxygen concentration on nasal NO output. Oxygen and nitrogen were blended to give gas mixes with final oxygen tensions of 0, 2.4, 4.9, 7.4, 9.9, 14.9, 20.9, 29.7, 49.8, 69.7, 89.9, and 100% at a flow rate of 2 l/min, each with [NO]in < 1 ppb. Nine subjects (24-36 yr old, 4 men and 5 women) were recruited for the study. All fulfilled the entry criteria described for experiments 1 and 2. [NO]out was measured during three experimental runs at each of the 12 different oxygen tensions, again in random order, for each subject. The nasal NO output (nl/min) was calculated according to American Thoracic Society guidelines, as for experiment 1, from [NO]out (ppb) × gas flow rate (l/min).
Statistics. For experiments 1 and 3, data are presented as means and 95% confidence intervals. An overall mean NO output has been calculated from the data for all subjects in these two experiments. For experiment 2, differences in DNO and Cw at the two luminal flow rates were assessed for statistical significance using a paired t-test.
All the experimental work was passed by the Birmingham Heartlands Hospital Local Research and Ethics Committee before commencement of the studies.| |
RESULTS |
|---|
|
|
|---|
Most subjects found the breath-holding maneuver easy to perform. The measurement of [NO]out was straightforward and reproducible using this method, with the rapid attainment of a steady state even at the lowest flow (0.5 l/min). The individual coefficients of variation ranged from 1.82% to 4.99%. The mean nasal NO output for experiments 1 and 3 was 334 nl/min.
Experiment 1: effect of luminal gas flow rate on nasal NO output.
[NO]out was >100 ppb at the lowest flow (0.5 l/min) but
declined as the flow of gas into the right nostril increased (Fig. 2A). However, as shown in Fig.
2B, when dilutional effects due to the higher gas flows were
taken into account, the nasal output for NO (nl/min) increased with
increasing gas flow. There was considerable between-subject variation
in nasal NO output. At 2 l/min, for instance, the nasal NO output
varied from 144 nl/min in one subject to 273 nl/min in another.
|
Experiment 2: effect of luminal NO concentration on
[NO]out.
When nonzero [NO] were introduced into the isolated nasal cavity,
[NO]out was a linear function of [NO]in in
all subjects (Fig. 3). Because this
function was found to be universally linear, we were able to apply the
model developed by Silkoff et al. (37) to determine nasal
DNO and nasal Cw at each flow rate for each subject (Table 1) using Eq. 3.
The mean nasal DNO was 1.80 × 10
3 and
1.86 × 10
3
nl · s
1 · ppb
1 when luminal
flow was 1 and 2 l/min, respectively (P = 0.78). The
mean nasal mucosal [NO] (Cw) declined with increasing
luminal gas flow from 4,935 ppb at 1 l/min to 2,511 ppb at 2 l/min
(P = 0.01). There was wide intersubject variation in
Cw, and although all values were lower at higher flow, the
difference in Cw between the two flows also showed wide
variation (Table 1).
|
|
[NO]in) × gas flow
rate} would be negligible.
Experiment 3: effect of luminal oxygen concentration on nasal NO
output.
Figure 4 displays the effect of
alterations in luminal oxygen tension on nasal NO output. Output
decreased with decreasing oxygen tension, although most of this effect
was noticeable at oxygen tensions <10%.
|
| |
DISCUSSION |
|---|
|
|
|---|
A number of conclusions regarding the nasal exchange dynamics of NO in healthy adults can be drawn from the results of this study. With increasing luminal gas flow rate, [NO] emitted from the nose declines. However, when the NO output (in nl/min) is calculated from the emitted concentration × gas flow rate, it is found to increase with increasing luminal gas flow rate, an effect previously described (5, 11). Nasal NO output ranged between ~100 and 500 nl/min in the three experiments, with an overall average of 334 nl/min. When nonzero [NO] are infused into the isolated nasal system at a particular flow rate, DNO and Cw can be easily calculated using the mathematical model. DNO does not vary with a doubling of luminal gas flow rate, but Cw declines roughly by one-half. Nasal NO output declined with decreasing luminal oxygen tension, an effect especially apparent at oxygen tensions <10%.
Before the findings are discussed, it is prudent to identify possible sources of variation in this study. A brief consideration of nasal anatomy and physiology is worthwhile. Inasmuch as the nasal cavity is bony, it is of relatively fixed volume. However, because the submucosal area is richly perfused with a venous vascular network, volume can, and indeed does, change. In some people, this happens in a cyclical fashion over hours. As the venous network dilates, the lumen of the nasal cavity shrinks, and as the network constricts, the lumen increases in volume (7). This feature of nasal physiology can potentially influence NO physiology in two ways. First, an increase in luminal volume tends to reduce luminal [NO] through simple dilution, with the assumption that NO production remains constant. Second, a decrease in submucosal blood reduces the availability of heme, with which NO reacts avidly (14), and so potentially increases the amount of NO excreted into the nasal lumen. Although these opposite effects will tend to oppose one another, Giraud et al. (10) demonstrate that the effect of nasal volume is probably greater. This group applied the topical vasoconstrictor oxymetazoline to the nasal mucosa of human volunteers and found that luminal [NO] decreased, an effect of the increase in nasal volume, rather than an effect of constriction in the volume of the vascular bed.
To simplify matters in terms of NO physiology, however, this cyclical change in nasal volume tends to occur in a see-saw fashion, with the left- and right-sided nasal volumes changing in opposite directions, so that the overall nasal volume remains relatively constant (7). Qian et al. (29) demonstrated that the effect of the nasal cycle on nasal NO output is minimal, and two groups have shown that nasal NO output does not vary between nostrils in healthy subjects (27, 29). Although changes in luminal temperature have no effect on nasal NO output (10), deep inhalation and breath holding tend to decrease the nasal resistance (i.e., increase luminal volume) (38), although this is unlikely to lead to bias in our study, since all experiments were conducted with the same deep inspiration and breath-holding maneuver. Because the nasal cavity is in communication with the paranasal sinuses, it is possible that some NO detected at the nares originates in the sinuses. High [NO] values have been found during direct sampling of the paranasal sinuses (12, 23); however, Haight et al. (12), in a study specifically designed to determine the relative contributions of the nose and paranasal sinuses to the NO appearing at the nares, found that 88% was produced in the nasal cavity itself. For all the subjects in this study, a stable [NO]out was obtained within 10 s. The rapidity of this response suggests a relatively simple NO-producing nasal cavity architecture, in keeping with the findings of Haight et al. Because, in the systemic vasculature, endothelial cells produce NO in response to shear stress (39), it is possible that changes in nasal pressure may alter NO production by nasal epithelial cells. However, changes in nasal pressure in our experiments are likely to be small, since the system is open, and previous work has demonstrated no effect of changes in airway pressure on lower respiratory tract NO output (2, 16).
The [NO] obtained at the left nostril and the calculated nasal NO outputs in our studies are in good agreement with those reported by other authors (5, 10, 18, 21). Imada et al. (18) found the average nasal NO output to be 323 nl/min in healthy men, and Giraud et al. (10) describe an average of 540 nl/min, whereas Kimberly et al. (21) found an average of 468 nl/min, compared with our overall average of 334 nl/min.
The relationship between nasal NO output and luminal gas flow rate has been studied systematically by others. Imada et al. (18) found a hyperbolic relationship between the [NO] collected in a bag after room air was pumped through the isolated nasal airway at flow rates between 0.5 and 2.0 l/min, leading them to conclude that nasal NO output is constant across different gas flows. It may have been that this range of flows was too narrow for detection of an effect of luminal gas flow on nasal NO output. On the other hand, Dubois et al. (5), using an experimental design similar to ours, demonstrate NO output as a positive function of luminal gas flow, but at a range of flows lower than those used in our study (8.2-347 ml/min), and Giraud et al. (11) also demonstrated a positive relationship, but at flows from 1 to 22 l/min.
We found that the infusion of nonzero [NO] into the isolated nasal
system allowed easy determination of nasal DNO and
Cw at a constant luminal gas flow rate. The mean
DNO and Cw in the lung in a group of 10 healthy
adults were 5.58 × 10
3
nl · s
1 · ppb
1 and 137 ppb,
respectively (37). We have found lower values for nasal
DNO in our group of eight healthy subjects
(0.52-2.98 × 10
3
nl · s
1 · ppb
1) but values
for Cw that are much higher and vary considerably between
individuals (1,236-8,947 ppb). These very high values for nasal
Cw are not unexpected given the high [NO] in the nasal lumen (20), but the degree of interindividual variation
raises the possibility of interindividual differences in NO-dependent nasal physiology.
The determination of DNO and Cw in the bronchial tree is possible only at multiple flow rates and with the assumption that Cw remains constant with varying flow, since [NO]in cannot be controlled (37). In the nose, we have demonstrated that Cw roughly halves with a doubling in luminal gas flow rate, suggesting that this assumption may be incorrect. In summary, with increasing luminal gas flow, the total nasal NO output increases, but the mucosal concentration declines. Taken together, these two findings support the hypothesis of Silkoff et al. (36) that changes in luminal gas flow induce a change in equilibrium between diffusion of NO to the submucosa and the lumen, such that an increase in gas flow favors diffusion toward the lumen and away from the submucosa. Because Cw declined with increasing luminal gas flow rate, it seems unlikely that the nasal epithelium acts in an analogous fashion to the vascular endothelium. That is, increases in luminal gas flow rate appear not to lead to an increase in NOS activity in nasal epithelial cells.
We have demonstrated that, especially at low oxygen tensions (<10%), nasal NO output declines markedly. This is in line with the findings of Haight et al. (13), who also demonstrate a reduction in nasal NO output with hypoxia, particularly at oxygen tensions <10%. The most obvious explanation for this finding, and one well pursued by Dweik et al. (6) in the lower respiratory tract, is that NO production declines, since oxygen is a substrate for NOS. This may well be the case, but other explanations need to be considered. A number of authors have examined the relationship between systemic hypoxia and nasal resistance. Maltais et al. (26) and Dinh et al. (4) demonstrated that nasal resistance decreases with progressive and transient systemic hypoxia in men, probably through a neural mechanism. However, a decrease in nasal resistance (that is, an increase in nasal luminal volume) would tend to lead to an increase in dwell time of gas infused at constant flow and a reduction in available submucosal heme and so, potentially, to an increase in NO output. In any case, significant systemic hypoxia is unlikely with a breath hold of 35 s in healthy adults. The effect of the local application of a hypoxic gas mixture on nasal resistance has been less well studied. Seelagy et al. (33) found no effect of changes in inspired oxygen tension on nasal resistance in decerebrate cats. In contrast, Syabbalo et al. (38), in a human study, describe a rapid 40% increase in nasal resistance with the application of a gas mixture containing 10% oxygen. They ascribe this effect to a local vasodilator action of hypoxia on the nasal vascular bed (38). This effect could lead to a reduction in nasal NO output through an increase in the availability of heme in the richly vascular submucosa for reaction with NO (14) or through a reduction in nasal volume, so reducing dwell time for a gas infused at a constant flow. At this stage, we can only speculate as to whether the effect of luminal oxygen tension on nasal NO output results from an effect on NOS activity or an effect on nasal resistance. Further studies with the determination of DNO and Cw at very low oxygen tensions may help resolve this issue.
The ease with which Cw and DNO may be determined in the nose means that this technique may be utilized to study, in more depth, many aspects of nasal physiology and pathophysiology. Because, in terms of NO physiology, there are similarities between the nasal and bronchial epithelium (both comprise ciliated, NOS-containing epithelial cells that demonstrate a positive relationship between luminal gas flow, luminal oxygen tension, and NO output), further studies in the nose may provide insight into NO exchange dynamics in the bronchial tree.
In summary, we have demonstrated that nasal NO output is a positive function of luminal gas flow rate, probably secondary to a shift in equilibrium resulting from dilutional changes in luminal [NO], rather than a direct effect of luminal gas flow on NOS activity. Nasal NO output declines with local hypoxia, as a direct effect of hypoxia on NOS activity or secondary to the vasodilatory effect of hypoxia on the nasal vascular bed. Infusing nonzero [NO] into the isolated nasal cavity allows the straightforward determination of Cw and DNO, and further application of this technique may improve our understanding of respiratory tract NO physiology and pathophysiology.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: J. G. Ayres, Dept. of Respiratory Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK (E-mail: AyresJ{at}heartsol.wmids.nhs.uk).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 15 January 2001; accepted in final form 13 June 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Asano, K,
Chee CB,
Gaston B,
Lilly CM,
Gerard C,
Drazen JM,
and
Stamler JS.
Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells.
Proc Natl Acad Sci USA
91:
10089-10093,
1994
2.
Byrnes, CA,
Dinarevic S,
Busst CA,
Shinebourne EA,
and
Bush A.
Effect of measurement conditions on measured levels of peak exhaled nitric oxide.
Thorax
52:
697-701,
1997[Abstract].
3.
Dillon, WC,
Hampl V,
Shultz PJ,
Rubins JB,
and
Archer SL.
Origins of breath nitric oxide in humans.
Chest
110:
930-938,
1996
4.
Dinh, L,
Maltais F,
and
Series F.
Influence of progressive and of transient hypoxia on upper airway resistance in normal humans.
Am Rev Respir Dis
143:
1312-1316,
1991[Web of Science][Medline].
5.
Dubois, AB,
Douglas JS,
Stitt JT,
and
Mohsenin V.
Production and absorption of nitric oxide gas in the nose.
J Appl Physiol
84:
1217-1224,
1998
6.
Dweik, RA,
Laskowski D,
Abu-Soud HM,
Kaneko F,
Hutte R,
Stuehr DJ,
and
Erzurum SC.
Nitric oxide synthesis in the lung: regulation by oxygen through a kinetic mechanism.
J Clin Invest
101:
660-666,
1998[Web of Science][Medline].
7.
Flannagan, P,
and
Eccles R.
Spontaneous changes in unilateral nasal airflow in man. A re-examination of the nasal cycle.
Acta Otolaryngol (Stockh)
117:
590-595,
1997[Medline].
8.
Furukawa, K,
Harrison DG,
Saleh D,
Shennib H,
Chagnon FP,
and
Giaid A.
Expression of nitric oxide synthase in the human nasal mucosa.
Am J Respir Crit Care Med
153:
847-850,
1996[Abstract].
9.
Gaston, B,
Drazen JM,
Loscalzo J,
and
Stamler JS.
The biology of nitrogen oxides in the airways.
Am J Respir Crit Care Med
149:
538-551,
1994[Abstract].
10.
Giraud, GD,
Nejadnik B,
Kimberly B,
and
Holden WE.
Effects of airflow, temperature or a topical vasoconstrictor on nasal nitric oxide release (Abstract).
FASEB J
9:
A326,
1995.
11.
Giraud, GD,
Nejadnik B,
Kimberly B,
and
Holden WE.
Physical characteristics and gas composition of nasal air affect nasal nitric oxide release.
Respir Physiol
114:
285-296,
1998[Web of Science][Medline].
12.
Haight, JSJ,
Djupesland PG,
Qjan W,
Chatkin JM,
Furlott H,
Irish J,
Witterick I,
McClean P,
Fenton RS,
Hoffstein V,
and
Zamel N.
Does nasal nitric oxide come from the sinuses?
J Otolaryngol
28:
197-204,
1999[Web of Science][Medline].
13.
Haight, JSJ,
Qian W,
Daya H,
Chalmers P,
and
Zamel N.
Hypoxia depresses nitric oxide output in the human nasal airways.
Laryngoscope
110:
429-433,
2000[Web of Science][Medline].
14.
Hakim, TS,
Sugimori K,
Camporesi EM,
and
Anderson G.
Half-life of nitric oxide in aqueous solutions with and without haemoglobin.
Physiol Meas
17:
267-277,
1996[Web of Science][Medline].
15.
Higenbottam, T.
Lung disease and pulmonary endothelial nitric oxide.
Exp Physiol
80:
855-864,
1995[Web of Science][Medline].
16.
Hogman, M,
Stromberg S,
Schedin U,
Frostell C,
Hedenstierna G,
and
Gustafsson E.
Nitric oxide from the human respiratory tract efficiently quantified by standardized single breath measurements.
Acta Physiol Scand
159:
345-346,
1997[Web of Science][Medline].
17.
Hyde, RW,
Geigel EJ,
Olszowka AJ,
Krasney JA,
Forster RE, 2nd,
Utell MJ,
and
Frampton MW.
Determination of production of nitric oxide by lower airways of humans
theory.
J Appl Physiol
82:
1290-1296,
1997
18.
Imada, M,
Iwamoto J,
Nonaka S,
Kobayashi Y,
and
Unno T.
Measurement of nitric oxide in human nasal airway.
Eur Respir J
9:
556-559,
1996[Abstract].
19.
Kharitonov, S,
Alving K,
and
Barnes PJ.
Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.
Eur Respir J
10:
1683-1693,
1997[Web of Science][Medline].
20.
Kharitonov, SA,
Rajakulasingam K,
O'Connor B,
Durham SR,
and
Barnes PJ.
Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids.
J Allergy Clin Immunol
99:
58-64,
1997[Web of Science][Medline].
21.
Kimberly, B,
Nejadnik B,
Giraud GD,
and
Holden WE.
Nasal contribution to exhaled nitric oxide at rest and during breath holding in humans.
Am J Respir Crit Care Med
153:
829-836,
1996[Abstract].
22.
Liao, JK,
Zulueta JJ,
Yu FS,
Peng HB,
Cote CG,
and
Hassoun PM.
Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen.
J Clin Invest
96:
2661-2666,
1995.
23.
Lundberg, JO,
Farkas-Szallasi T,
Weitzberg E,
Rinder J,
Lidholm J,
Anggaard A,
Hokfelt T,
Lundberg JM,
and
Alving K.
High nitric oxide production in human paranasal sinuses.
Nat Med
1:
370-373,
1995[Web of Science][Medline].
24.
Lundberg, JO,
Weitzberg E,
Rinder J,
Rudehill A,
Jansson O,
Wiklund NP,
Lundberg JM,
and
Alving K.
Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa.
Eur Respir J
9:
1344-1347,
1996[Abstract].
25.
Lundberg, JON,
and
Weitzberg E.
Nasal nitric oxide in man.
Thorax
54:
947-952,
1999
26.
Maltais, F,
Dinh L,
Cormier Y,
and
Series F.
Changes in upper airway resistance during progressive normocapnic hypoxia in normal men.
J Appl Physiol
70:
548-553,
1991
27.
Olin, A,
Toren K,
Ljungkvist G,
Nielsen J,
and
Granung G.
Measurement of nasal nitric oxide (Abstract).
Eur Respir J
12 Suppl28:
249S,
1998.
28.
Palmer, RM,
Ferrige AG,
and
Moncada S.
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Nature
327:
524-526,
1987[Medline].
29.
Qian, W,
Chatkin JM,
Diupesland PG,
McClean P,
Zamel N,
Irish J,
and
Haight J.
Advantages of unilateral nasal nitric oxide measurement vs. bilateral measurement (Abstract).
Am J Respir Crit Care Med
159:
A865,
1999.
30.
Ramis, I,
Lorente J,
Rosello-Catafau J,
Quesada P,
Gelpi E,
and
Bulbena O.
Differential activity of nitric oxide synthase in human nasal mucosa and polyps.
Eur Respir J
9:
202-206,
1996[Abstract].
31.
Robbins, RA,
Barnes PJ,
Springall DR,
Warren JB,
Kwon OJ,
Buttery LD,
Wilson AJ,
Geller DA,
and
Polak JM.
Expression of inducible nitric oxide in human lung epithelial cells.
Biochem Biophys Res Commun
203:
209-218,
1994[Web of Science][Medline].
32.
Schmetterer, L,
Strenn K,
Kastner J,
Eichler HG,
and
Wolzt M.
Exhaled NO during graded changes in inhaled oxygen in man.
Thorax
52:
736-738,
1997[Abstract].
33.
Seelagy, MM,
Schwartz AR,
Russ DB,
King ED,
Wise RA,
and
Smith PL.
Reflex modulation of airflow dynamics through the upper airway.
J Appl Physiol
76:
2692-2700,
1994
34.
Shaul, PW,
North AJ,
Wu LC,
Wells LB,
Brannon TS,
Lau KS,
Michel T,
Margraf LR,
and
Star RA.
Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium.
J Clin Invest
94:
2231-2236,
1994.
35.
Silkoff, PE.
Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children
1999.
Am J Respir Crit Care Med
160:
2104-2117,
1999
36.
Silkoff, PE,
McClean PA,
Slutsky AS,
Furlott HG,
Hoffstein E,
Wakita S,
Chapman KR,
Szalai JP,
and
Zamel N.
Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide.
Am J Respir Crit Care Med
155:
260-267,
1997[Abstract].
37.
Silkoff, PE,
Sylvester JT,
Zamel N,
and
Permutt S.
Airway nitric oxide diffusion in asthma. Role in pulmonary function and bronchial responsiveness.
Am J Respir Crit Care Med
161:
1218-1228,
2000
38.
Syabbalo, NC,
Bundgaard A,
Entholm P,
Schmidt A,
and
Widdicombe JG.
Measurement and regulation of nasal airflow resistance in man.
Rhinology
24:
87-101,
1986[Medline].
39.
Takahashi, M,
Ishida T,
Traub O,
Corson MA,
and
Berk BC.
Mechanotransduction in endothelial cells: temporal signaling events in response to shear stress.
J Vasc Res
34:
212-219,
1997[Web of Science][Medline].
40.
Tsoukias, NM,
and
George SC.
A two-compartment model of pulmonary nitric oxide exchange dynamics.
J Appl Physiol
85:
653-666,
1998
This article has been cited by other articles:
![]() |
L. Menzel, A. Hess, W. Bloch, O. Michel, K.-D. Schuster, R. Gabler, and W. Urban Temporal nitric oxide dynamics in the paranasal sinuses during humming J Appl Physiol, June 1, 2005; 98(6): 2064 - 2071. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maniscalco, E. Weitzberg, J. Sundberg, M. Sofia, and J.O. Lundberg Assessment of nasal and sinus nitric oxide output using single-breath humming exhalations Eur. Respir. J., August 1, 2003; 22(2): 323 - 329. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |